tirzepatide is better than semaglutide vs. Semaglutide: What You Should Know what is stronger than tirzepatide

The pipeline is filled with new developments that will likely increase their use and market impact for years to come

The glomerular podocyte as a target of growth hormone action: implications for the pathogenesis of diabetic nephropathy

Recently approved for cardiovascular disease management by the FDA in March 2024, Wegovy is the first weight loss medication to offer this dual benefit

For inflammatory conditions, topical NSAIDs may provide localised relief with reduced systemic exposure and lower risk of side effects

To minimize the risk of urgent bowel movements or stomach upset, it is best to avoid high-fat, greasy, or fried foods, as well as sugary snacks and drinks